Guizhou Yibai Pharmaceutical Co Ltd Strategic Asset Allocation Index
Guizhou Yibai Pharmaceutical Co Ltd strategic asset allocation index. Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Strategic Asset Allocation Index of 54.3% as of June 2023. Strategic assets (PP&E of CN¥1.80 Billion plus long-term investments of CN¥-) total CN¥1.80 Billion, measured against net assets of CN¥3.31 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Guizhou Yibai Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guizhou Yibai Pharmaceutical Co Ltd (2001–2022)
Strategic asset allocation index of Guizhou Yibai Pharmaceutical Co Ltd from 2001 to 2022. This chart shows how Guizhou Yibai Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2001 to 2022. As of June 2023, the index stands at 54.3%, representing strategic assets of CN¥1.80 Billion against net assets of CN¥3.31 Billion CNY.
Guizhou Yibai Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2001–2022)
Guizhou Yibai Pharmaceutical Co Ltd strategic asset allocation index by year from 2001 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guizhou Yibai Pharmaceutical Co Ltd from 2001 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guizhou Yibai Pharmaceutical Co Ltd (600594) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 57.3% | CN¥1.83 Billion | CN¥1.83 Billion | CN¥- | CN¥3.19 Billion | ▲ +9.3 pp |
| 2021 | 48.0% | CN¥1.71 Billion | CN¥1.71 Billion | CN¥- | CN¥3.56 Billion | ▲ +7.0 pp |
| 2020 | 41.0% | CN¥1.42 Billion | CN¥1.42 Billion | CN¥- | CN¥3.46 Billion | ▲ +6.3 pp |
| 2019 | 34.6% | CN¥1.29 Billion | CN¥1.29 Billion | CN¥- | CN¥3.72 Billion | ▼ -1.7 pp |
| 2018 | 36.4% | CN¥1.42 Billion | CN¥1.42 Billion | CN¥- | CN¥3.91 Billion | ▲ +3.1 pp |
| 2017 | 33.3% | CN¥1.54 Billion | CN¥1.54 Billion | CN¥- | CN¥4.64 Billion | ▲ +1.4 pp |
| 2016 | 31.9% | CN¥1.34 Billion | CN¥1.34 Billion | CN¥- | CN¥4.19 Billion | ▲ +4.0 pp |
| 2015 | 27.9% | CN¥990.02 Million | CN¥990.02 Million | CN¥- | CN¥3.55 Billion | ▲ +6.7 pp |
| 2014 | 21.2% | CN¥726.13 Million | CN¥726.13 Million | CN¥- | CN¥3.42 Billion | ▼ -7.0 pp |
| 2013 | 28.2% | CN¥544.98 Million | CN¥544.98 Million | CN¥- | CN¥1.93 Billion | ▲ +9.1 pp |
| 2012 | 19.1% | CN¥294.90 Million | CN¥294.90 Million | CN¥- | CN¥1.55 Billion | ▼ -7.0 pp |
| 2011 | 26.1% | CN¥296.77 Million | CN¥296.77 Million | CN¥- | CN¥1.14 Billion | ▼ -12.2 pp |
| 2010 | 38.3% | CN¥335.52 Million | CN¥335.52 Million | CN¥- | CN¥876.05 Million | ▼ -5.7 pp |
| 2009 | 44.0% | CN¥312.63 Million | CN¥312.63 Million | CN¥- | CN¥710.95 Million | ▼ -28.4 pp |
| 2008 | 72.3% | CN¥432.74 Million | CN¥432.74 Million | CN¥- | CN¥598.16 Million | ▼ -1.5 pp |
| 2007 | 73.8% | CN¥391.43 Million | CN¥391.43 Million | CN¥- | CN¥530.04 Million | ▼ -2.1 pp |
| 2006 | 75.9% | CN¥323.30 Million | CN¥323.30 Million | CN¥- | CN¥425.69 Million | ▲ +16.3 pp |
| 2005 | 59.7% | CN¥326.54 Million | CN¥326.54 Million | CN¥- | CN¥547.39 Million | ▲ +0.1 pp |
| 2004 | 59.5% | CN¥301.55 Million | CN¥301.55 Million | CN¥- | CN¥506.70 Million | ▼ -36.9 pp |
| 2003 | 96.4% | CN¥173.80 Million | CN¥173.80 Million | CN¥- | CN¥180.22 Million | ▲ +56.2 pp |
| 2002 | 40.2% | CN¥51.59 Million | CN¥51.59 Million | CN¥- | CN¥128.20 Million | ▼ -2.9 pp |
| 2001 | 43.1% | CN¥35.64 Million | CN¥35.64 Million | CN¥- | CN¥82.63 Million | — |